Jennifer M Jones, PhD

Dr. Jones' research program has focused primarily on the quality of life and psychosocial issues of individuals and families facing cancer. Her most recent scholarly and professional activities have clustered around the following platforms:
  • Translational research to inform clinical survivorship care
    This platform specifically focuses on examining new approaches to predict, prevent and manage long-term adverse effects of cancer and its treatment and evaluating innovative models of follow-up care and support. This includes: i) Assessment of the prevalence and impact of long-term and late physical and psychosocial effects of cancer and its treatment; ii) Development and evaluation of sustainable and cost-effective psychosocial and self-management interventions for patients and their families and innovative models of care; 3) Integration of evidence into daily clinical practice through the development of integrated KT models and education.
  • Fostering innovative health professional and continuing education that is designed to transform the patient experience
    This area of research has included the development and formal evaluation of multidisciplinary training programs in psychosocial oncology and palliative care, patient education, and cancer survivorship care.

Related Links

Lancet Oncol. 2018 Sep;19(9):e433-e436
Mina DS, Langelier D, Adams SC, Alibhai SMH, Chasen M, Campbell KL, Oh P, Jones JM, Chang E
Nature. 2018 Aug 22;:
Ahmadi M, Alves BXR, Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Cohen S, Collister R, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Hangst JS, Hardy WN, Hayden ME, Hunter ED, Isaac CA, Johnson MA, Jones...
Int J Behav Nutr Phys Act. 2018 Jun 07;15(1):49
Trinh L, Arbour-Nicitopoulos KP, Sabiston CM, Berry SR, Loblaw A, Alibhai SMH, Jones JM, Faulkner GE
Support Care Cancer. 2018 May 29;:
Eng L, Pringle D, Su J, Shen X, Mahler M, Niu C, Charow R, Tiessen K, Lam C, Halytskyy O, Naik H, Hon H, Irwin M, Pat V, Gonos C, Chan C, Villeneuve J, Harland L, Shani RM, Brown MC, Selby P, Howell D, Xu W, Liu G, Alibhai SMH, Jones JM
Ann Neurol. 2018 May 07;:
Husain AM, Lee JW, Kolls BJ, Hirsch LJ, Halford JJ, Gupta PK, Minazad Y, Jones JM, LaRoche SM, Herman ST, Swisher CB, Sinha SR, Palade A, Dombrowski KE, Gallentine WB, Hahn CD, Gerard EE, Bhapkar M, Lokhnygina Y, Westover MB, Critical Care EEG...
Curr Oncol. 2018 Apr;25(2):149-162
Mina DS, Sabiston CM, Au D, Fong AJ, Capozzi LC, Langelier D, Chasen M, Chiarotto J, Tomasone JR, Jones JM, Chang E, Culos-Reed SN
J Oncol Pract. 2018 Apr 20;:JOP1700029
Alton D, Eng L, Lu L, Song Y, Su J, Farzanfar D, Mohan R, Krys O, Mattina K, Harper C, Liu S, Yoannidis T, Milne R, Brown MC, Vennettilli A, Hope AJ, Howell D, Jones JM, Selby P, Xu W, Goldstein DP, Liu G, Giuliani ME
BMJ Open. 2018 Apr 12;8(4):e020298
Sawka AM, Ghai S, Tomlinson G, Rotstein L, Gilbert R, Gullane P, Pasternak J, Brown D, de Almeida J, Irish J, Chepeha D, Higgins K, Monteiro E, Jones JM, Gafni A, Goldstein DP
Nature. 2018 Apr 04;:
Ahmadi M, Alves BXR, Baker CJ, Bertsche W, Capra A, Carruth C, Cesar CL, Charlton M, Cohen S, Collister R, Eriksson S, Evans A, Evetts N, Fajans J, Friesen T, Fujiwara MC, Gill DR, Hangst JS, Hardy WN, Hayden ME, Isaac CA, Johnson MA, Jones JM, Jones...

Pages


Director, Cancer Rehabilitation and Survivorship Program, Princess Margaret Cancer Centre
Associate Professor, Department of Psychiatry (primary) and Dalla Lana School of Public Health (cross-appointment), University of Toronto
Co-Lead, Canadian Cancer Survivorship Research Consortium (www.ccsrc.ca)